These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16649404)

  • 1. [The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology].
    van Lieshout J; Rutten FH; Walma EP; Wiersma TJ; Goudswaard AN
    Ned Tijdschr Geneeskd; 2006 Apr; 150(14):818-9. PubMed ID: 16649404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Summary of the practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners].
    van Lieshout J; Rutten FH; Walma EP; Wiersma T; Goudswaard AN;
    Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2668-72. PubMed ID: 16358616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology].
    Ypenburg C; Schalij MJ; van der Wall EE
    Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2655-8. PubMed ID: 16358613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of general practice].
    Stalman WA
    Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2653-4. PubMed ID: 16358612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ambiguities in the diagnosis of heart failure].
    van Rijsingen IA; Pinto YM; Kok WE
    Ned Tijdschr Geneeskd; 2011; 155():A3159. PubMed ID: 21418704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH; Apple FS; Ravkilde J; Wu AH;
    Circulation; 2007 Jul; 116(5):e99-109. PubMed ID: 17630410
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Souverijn JH
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):231; author reply 231. PubMed ID: 18320951
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosing acute heart failure: the mathematician and the clinician.
    Dickstein K
    J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
    [No Abstract]   [Full Text] [Related]  

  • 11. Redefining heart failure.
    Thomas MD; Fox KF; Coats AJ
    Int J Cardiol; 2006 Sep; 112(2):139-41. PubMed ID: 16581144
    [No Abstract]   [Full Text] [Related]  

  • 12. BNP for clinical monitoring of heart failure.
    Troughton RW; Richards AM
    Heart Fail Clin; 2006 Jul; 2(3):333-43. PubMed ID: 17386902
    [No Abstract]   [Full Text] [Related]  

  • 13. B-type natriuretic peptides and the general practitioner.
    Mueller C
    J Am Coll Cardiol; 2007 Oct; 50(17):1702-3. PubMed ID: 17950154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers in heart failure. Does prognostic utility translate to clinical futility?
    Maisel A
    J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sensitivity, specificity, positive and negative predictive value of a diagnostic test].
    Nendaz MR; Perrier A
    Rev Mal Respir; 2004 Apr; 21(2 Pt 1):390-3. PubMed ID: 15211250
    [No Abstract]   [Full Text] [Related]  

  • 17. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; Cannon CP; Francis G; Jesse RL; Morrow DA; Newby LK; Storrow AB; Tang WH; Pagani F; Tate J; Ordonez-Llanos J; Mair J; ;
    Circulation; 2007 Jul; 116(5):e95-8. PubMed ID: 17630411
    [No Abstract]   [Full Text] [Related]  

  • 18. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
    Carvalho VO
    Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
    [No Abstract]   [Full Text] [Related]  

  • 19. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
    Javadzadeh J; Collén AC; Manhem K; Swedberg K
    Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
    [No Abstract]   [Full Text] [Related]  

  • 20. [BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation].
    Jernberg T; Boman K; James S; Lindahl B; Stridsberg M; Swedberg K; Venge P
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1289-92, 1295. PubMed ID: 16708856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.